Life Science News and Press Releases

Avacta extends Optim® 2 product family for even greater measurement flexibility

Avacta Analytical

10/10/2014

Avacta’s Optim® 2 platform is an innovative analytical instrument designed to probe multiple protein stability indicating parameters at high speed using ultra-low sample volumes. Developed to reduce the time and cost of therapeutic protein preformulation studies, the functionality of this compact instrument family has now been further enhanced with the addition of two new models. The Optim 375 is intended for the investigation of complex mixtures of...

Software updates simplify protein analysis for Avacta’s Optim® instruments

Avacta Analytical

30/07/2014

Avacta Analytical has released a number of software updates for its innovative Optim® series of biophysical characterization instruments. Designed to reduce the time and cost of therapeutic protein preformulation studies, the compact and robust Optim instruments can probe multiple protein stability¬ indicating parameters at high speed using ultra-low sample volumes. The latest software updates have been developed to streamline this process, offering faster, more...

Reinventing buffer screening with Avacta’s Optim technology

Avacta Analytical

18/03/2014

Avacta’s Optim protein stability analysis technology is helping researchers at Manchester University to approach buffer selection in an entirely new way. Dr Tom Jowitt, Manager of the University’s Biomolecular Analysis Core Facility, explained: “Academic institutions tend to work by word of mouth on protein projects, sticking to buffer conditions they are familiar with, or that have been used on previous projects within the laboratory. The buffers in use...

Straightforward protein characterisation at the NKI

Avacta Analytical

11/11/2013

Researchers at the Netherlands Cancer Institute (Nederlands Kanker Instituut, NKI) are benefitting from the advanced, multi-parameter characterisation offered by Avacta Analytical’s Optim® technology for the study of novel proteins. Dr Anastassis Perrakis, Principle Investigator in the Institute’s Structural Biology Group, explained: “We are interested in the mechanisms controlling a variety of different cellular processes, using in vitro protein...